A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10542-10553

  Lu, Li ^a   Palaniyandi, Senthilkumar ^a   Zeng, Rongyu ^a   Bai, Yu ^a   Liu, Xindong ^a   Wang, Yunsheng ^a   Pauza, C David ^b   Roopenian, Derry C ^c   Zhu, Xiaoping ^a,d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JACKSON LABORATORY   (United States)

^d University of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FC RECEPTOR; GAG FC PROTEIN; GAG PROTEIN; HYBRID PROTEIN; NEONATAL FC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; LUNG ALVEOLUS EPITHELIUM; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; RESPIRATORY TRACT MUCOSA; T LYMPHOCYTE; VACCINIA VIRUS; VAGINITIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; AIDS VACCINES; ANIMALS; B-LYMPHOCYTES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV CORE PROTEIN P24; HIV INFECTIONS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; VACCINIA VIRUS;

EID: 80054967594     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05441-11     Document Type: Article

References (52)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54-60.
2. Belyakov, I. M., and J. A. Berzofsky. 2004. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20:247-253.
3. Bernasconi, N. L., E. E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
4. Bitonti, A. J., et al. 2004. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc. Natl. Acad. Sci. U. S. A. 101:9763-9768.
5. Boscardin, S. B., et al. 2006. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203:599-606.
6. Broliden, K., A. T. Haase, S. K. Ahuja, G. M. Shearer, and J. Andersson. 2009. Introduction: back to basics: mucosal immunity and novel HIV vaccine concepts. J. Intern. Med. 265:5-17.
7. Burmeister, W. P., L. N. Gastinel, N. E. Simister, M. L. Blum, and P. J. Bjorkman. 1994. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 372:336-343.
8. Chargelegue, D., C. M. Stanley, C. M. O'Toole, B. T. Colvin, and M. W. Steward. 1995. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin. Exp. Immunol. 99:175-181.
9. Demberg, T., and M. Robert-Guroff. 2009. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int. Rev. Immunol. 28:20-48.
10. Dickinson, B. L., et al. 1999. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest. 104:903-911.
11. + T cell memory by promoting the generation of IL-7Rα-expressing cells. J. Exp. Med. 204:547-557.
12. Duncan, A. R., and G. Winter. 1988. The binding site for C1q on IgG. Nature 332:738-740.
13. Forthal, D. N., G. Landucci, and E. S. Daar. 2001. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J. Virol. 75:6953-6961.
14. French, M. A., et al. 2010. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. AIDS 24:1983-1990.
15. Gallichan, W. S., and K. L. Rosenthal. 1998. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 177:1155-1161.
16. Ghetie, V., et al. 1996. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur. J. Immunol. 26:690-696.
17. Gupta, S., et al. 2005. Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles. J. Virol. 79:7135-7145.
18. Haase, A. T. 2011. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu. Rev. Med. 62:127-139.
19. Hansen, S. G., et al. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15:293-299.
20. Hao, Z., et al. 2008. FAs receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 29:615-627.
21. Israel, E. J., D. F. Wilsker, K. C. Hayes, D. Schoenfeld, and N. E. Simister. 1996. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 89:573-578.
22. Junghans, R. P., and C. L. Anderson. 1996. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. U. S. A. 93:5512-5516.
23. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53.
24. Kim, J. K., M. F. Tsen, V. Ghetie, and E. S. Ward. 1994. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur. J. Immunol. 24:2429-2434.
25. Léonetti, M., et al. 1998. Increasing immunogenicity of antigens fuses to Ig-binding proteins by cell surface targeting. J. Immunol. 160:3820-3827.
26. Li, Z., et al. 2011. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. U. S. A. 108:4388-4393.
27. Liu, J., et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
28. Liu, X., et al. 2008. Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J. Immunol. 181:449-463.
29. Liu, X., et al. 2011. The neonatal FcR-mediated presentation of immunecomplexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J. Immunol. 186:4674-4686.
30. McGhee, J. R. 2011. A mucosal gateway for vaccines. Nat. Biotechnol. 29:136-138.
31. Mestecky, J., M. Raska, J. Novak, R. C. R. C. Alexander, and Z. Moldoveanu. 2010. Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. J. Reprod. Immunol. 85:81-85.
32. Mi, W., et al. 2008. Targeting the neonatal Fc receptor for antigen delivery using engineered fc fragments. J. Immunol. 181:7550-7561.
33. Misumi, S., et al. 2009. Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. J. Immunol. 182:6061-6070.
34. Moyron-Quiroz, J. E., et al. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10:927-934.
35. Neutra, M. R., N. J. Mantis, and J.-P. Kraehenbuhl. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004-1009.
36. Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6:148-158.
37. Nochi, T., et al. 2007. A novel M cell specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 204:2789-2796.
38. Pal, S., E. M. Peterson, and L. M. de la Maza. 1996. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun. 64:5341-5348.
39. Parr, E. L., and M. B. Parr. 1997. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71:8109-9115.
40. Qiao, S. W., et al. 2008. Dependence of antibody-mediated presentation of antigen on FcRn. Proc. Natl. Acad. Sci. U. S. A. 105:9337-9342.
41. Rawool, D. B., et al. 2008. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J. Immunol. 180:5548-5557.
42. Roopenian, D. C., and S. Akilesh. 2007. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7:715-725.
43. Roopenian, D. C., et al. 2003. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Immunol. 170:3528-3533.
44. Spiekermann, G. M., et al. 2002. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 196:303-310.
45. Tesar, D. B., N. E. Tiangco, and P. J. Bjorkman. 2006. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic 7:1127-1142.
46. + T cell immunity in mice with anti-dendritic cell HIV Gag fusion antibody vaccine. J. Exp. Med. 203:607-617.
47. van Duin, D., R. Medzhitov, and A. C. Shaw. 2006. Triggering TLR signaling in vaccination. Trends Immunol. 27:49-55.
48. Ward, E. S., and R. J. Ober. 2009. Chapter 4: multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv. Immunol. 103:77-115.
49. Wu, H. Y., H. Nguyen, and M. W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46:506-513.
50. Ye, L., R. Zeng, Y. Bai, D. C. Roopenian, and X. Zhu. 2011. Efficient mucosal delivery of vaccine using the FcRn-mediated IgG transfer pathway. Nat. Biotechnol. 29:158-163.
51. Ye, L., et al. 2008. The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/ lysosomal compartments. J. Immunol. 181:2572-2585.
52. Yoshida, M., et al. 2004. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20:769-783.